CD274 and nasopharyngeal carcinoma: The results demonstrated that PD-L1 partially reversed the anti-tumor effect of BRD7 in vivo (Figure S5C-E), reaffirming that BRD7 could promote T cell-mediated killing of tumor cells by downregulating PD-L1 expression, thereby inhibiting immune escape in NPC.